Search Results
You are looking at 1 - 10 of 10 items for
- Author: J J Gagliardino x
- Refine by access: All content x
Search for other papers by A M Cortizo in
Google Scholar
PubMed
Search for other papers by J J Gagliardino in
Google Scholar
PubMed
Abstract
The aim of this study was to demonstrate the feasibility of in vitro non-enzymatic glycosylation of IGF-binding protein-3 (IGFBP-3) and whether this process affects its binding properties and its modulatory effect on IGF-I mitogenic activity. Swiss 3T3 fibroblasts were cultured and the IGFBP-3 released into the medium (CM) glycated with either labelled or unlabelled glucose. Parallel glycation studies were performed using standard human IGFBP-3. Both species of IGFBP-3 became effectively glycated in a dose-dependent manner. Glycated IGFBP-3 bound larger amounts of 125I-labelled IGF-I than its non-glycated form. According to Scatchard analysis this effect might be due to an increase in the number of binding sites of the IGFBP-3 molecule rather than to changes in its affinity constants, which remain unchanged. Preincubation of fibroblasts with CM containing IGFBP-3 for 16 h before the addition of IGF-I enhanced the stimulatory effect of the hormone on thymidine incorporation into cell DNA. This potentiation was blunted when in vitro glycated instead of non-glycated IGFBP-3 was employed. These results provide further evidence of the in vitro glycation of IGFBP-3 and demonstrate that this process affects both its binding properties and its enhancing effect on IGF-I mitogenic activity. These changes may explain, at least partially, the development of many alterations observed in poorly controlled diabetic patients.
Journal of Endocrinology (1995) 144, 119–126
Search for other papers by A. M. Cortizo in
Google Scholar
PubMed
Search for other papers by J. J. Gagliardino in
Google Scholar
PubMed
ABSTRACT
The purpose of this work was to study the effect of diabetes on 125I-labelled insulin-like growth factor (IGF) binding to specific serum binding proteins (IGFBPs) and the possible role of protein glycation in such an effect. Accordingly, ligand blotting and fructosamine assays were performed in serum samples from diabetic and non-diabetic eSS rats as well as in samples of normal rat serum previously incubated with different concentrations of glucose.
IGFBPs with molecular weights of 24, 30 and 40 kDa were identified in samples from diabetic and non-diabetic rats. 125I-Labelled IGF-I binding to each of these fractions increased significantly in the serum of diabetic rats. IGF-I binding to IGFBP-40 increased significantly as a function of the degree of glycation of serum proteins. Conversely, the increased binding of IGFBP-24 and IGFBP-30 was related only to the glucose concentration attained at 120 min during the oral glucose tolerance test.
Glycation of proteins of normal serum and the binding of labelled IGF-I increased as a function of glucose concentration in the incubation media. In these in-vitro glycated normal sera, only the binding to IGFBP-40 increased significantly; this increase was closely related to the amount of protein glycation. No clear and reproducible changes occurred with the binding of 125I-labelled IGF-I to IGFBP-24 and IGFBP-30 fractions.
These results confirm the increase in the binding capacity of IGFBPs reported in diabetic animals. They also show that the increase in IGF-I binding to each IGFBP fraction is regulated by a different mechanism; whereas protein glycation induces changes in IGFBP-40, this mechanism does not affect the binding properties of the other two IGFBPs.
The increased binding of IGFBP might affect the availability of free IGF-I, and the consequent alterations in IGF-I-dependent metabolic processes could explain the role of this growth factor in the pathogenesis of chronic complications of diabetes.
Journal of Endocrinology (1991) 131, 33–38
Search for other papers by J. J. GAGLIARDINO in
Google Scholar
PubMed
Search for other papers by MARÍA TERESA PESSACQ in
Google Scholar
PubMed
SUMMARY
The effect of a single dose of insulin i.u./kg, i.p.) injected every 4 h during a 24-h period was studied in normal mice. The glycogen content of the diaphragm muscle and serum glucose levels were determined every 15 min throughout a period of 60 min after the hormone injection. Although insulin always produced an increase in glycogen and a decline in serum glucose, neither the sequential changes observed during the 60 min after injection nor the magnitude of these changes were constant throughout the 24 h of the day. The two circadian variations in the action of insulin (on glycogen and glucose) did not display any well-defined relationship, i.e. the most marked decline in glucose was not followed by a correspondingly marked increase in glycogen. These observations suggest that the results obtained from the administration of a single dose of insulin at an arbitrary time of day might be misleading. The circadian variations found could represent another component of the complex homeostatic mechanisms in which insulin is involved.
Search for other papers by J. J. GAGLIARDINO in
Google Scholar
PubMed
Search for other papers by MARÍA TERESA PESSACQ in
Google Scholar
PubMed
Search for other papers by R. E. HERNÁNDEZ in
Google Scholar
PubMed
Cátedra de Fisiología con Biofísica, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, 60y 120, 1900 La Plata, Argentina
(Received 23 July 1976)
There is general agreement that glucose-induced insulin release is mediated by a complex mechanism (Randle & Hales, 1972). It has also been postulated that cyclic AMP might play an important role in this process. However, conflicting results have been reported about the effect of glucose on cyclic AMP levels in the islets of Langerhans (Charles, Fanska, Schmid, Forsham & Grodsky, 1973; Cooper, Ashcroft & Randle, 1973). Since it has been shown that cyclic AMP release from the liver rather than its intracellular concentration is better related to some metabolic effects (Exton & Park, 1972), we felt that a similar correlation might exist in the β cell. The release of both insulin and cyclic AMP by isolated islets was measured in the presence of various glucose concentrations.
Search for other papers by C. M. Gronda in
Google Scholar
PubMed
Search for other papers by G. B. Diaz in
Google Scholar
PubMed
Search for other papers by J. P. F. C. Rossi in
Google Scholar
PubMed
Search for other papers by J. J. Gagliardino in
Google Scholar
PubMed
ABSTRACT
Using medium with a low ionic strength, a low concentration of Ca2+ and Mg2+ and devoid of K+, we have measured Ca2+-ATPase activity in the homogenates of rat islets preincubated for 3 min with several hormones in the presence of 3·3 mmol glucose/l. Insulin secretion was also measured in islets incubated for 5 min under identical experimental conditions. Islets preincubated with glucose (3·3 mmol/l) and glucagon (1·4 μmol/l) plus theophylline (10 mmol/l), ACTH (0·11 nmol/l), bovine GH (0·46 μmol/l), prolactin (0·2 μmol/l) or tri-iodothyronine (1·0 nmol/l) have significantly lower Ca2+-ATPase activity than those preincubated with only 3·3 mmol glucose/l. All these hormones increased the release of insulin significantly.
Dexamethasone (0·1 μmol/l) and somatostatin (1·2 μmol/l) enhanced the Ca2+-ATPase activity while adrenaline (10 μmol/l) did not produce any significant effect on the activity of the enzyme. These hormones decreased the release of insulin significantly.
These results demonstrated that islet Ca2+-ATPase activity was modulated by the hormones tested. Their inhibitory or enhancing effect seemed to be related to their effect on insulin secretion; i.e. those which stimulated the secretion of insulin inhibited the activity of the enzyme and vice versa. Hence, their effect on insulin secretion may be due, in part, to their effect on enzyme activity and consequently on the concentration of cytosolic Ca2+. These results reinforce the assumption that Ca2+-ATPase activity participates in the physiological regulation of insulin secretion, being one of the cellular targets for several agents which affect this process.
Journal of Endocrinology (1992) 134, 221–225
Search for other papers by B Maiztegui in
Google Scholar
PubMed
Search for other papers by M I Borelli in
Google Scholar
PubMed
Search for other papers by M A Raschia in
Google Scholar
PubMed
Search for other papers by H Del Zotto in
Google Scholar
PubMed
Search for other papers by J J Gagliardino in
Google Scholar
PubMed
β-Cell mass, hexokinase/glucokinase (HK/GK) activity, glucose metabolism and insulin secretion were studied in the islets of rats with fructose-induced insulin resistance (IR). Normal male Wistar rats were fed a standard commercial diet and water without (control, C) or with 10% fructose-rich diet (FRD) for 3 weeks. Blood glucose (strips), triglyceride (commercial kit), and insulin (RIA) levels were measured at the time of death. Glucose-induced insulin release, glucose metabolism (14CO2 and 3H2O production from d-[U-14C]- and d-[5-3H]-glucose) and HK/GK activity (G-6-P production), transcription (RT-PCR), protein expression (Western blot), and cellular compartmentalization were measured in isolated islets (collagenase digestion). FRD rats presented normoglycemia but impaired glucose tolerance, hypertriglyceridemia, hyperinsulinemia, and increased HOMA-IR index. In these rats, β-cell mass decreased significantly by 33%, with a 44% increase in the percentage of apoptotic cells. Glucose-induced insulin release and islet glucose metabolism were higher in FRD rats. While GK activity (total and cytosolic fraction) and protein expression were significantly higher in FRD islets, HK showed no change in any of these parameters. Our results demonstrate that the changes induced by dietary-induced IR upon β-cell function and mass are strongly conditional on the nutrient model used. In our model (intact animals with impaired glucose tolerance), GK activity increases through mechanisms previously shown only in vitro or under highly hyperglycemic conditions. Such an increase plays a pivotal role in the adaptive increased release of insulin in response to IR, even in the presence of marked β-cell mass reduction.
Search for other papers by J. J. GAGLIARDINO in
Google Scholar
PubMed
Search for other papers by MARÍA TERESA PESSACQ in
Google Scholar
PubMed
Search for other papers by R. E. HERNÁNDEZ in
Google Scholar
PubMed
Search for other papers by O. R. REBOLLEDO in
Google Scholar
PubMed
CENEXA—Centro de Endocrinología Experimentaly Aplicada, CONICET—Universidad Nacional de La Plata, Facultad de Ciencias Médicas, Calle 60 y 120, 1900 La Plata, Argentina
(Received 10 March 1978)
Circadian variations in the serum concentration of immunoreactive insulin in the mouse (Gagliardino & Hernández, 1971) and the effect of fasting and feeding on this rhythm (Pessacq, Rebolledo, Mercer & Gagliardino, 1976) have already been described. However, no information is available on circadian variations in the level of glucagon in the blood of experimental animals and the present experiments were performed to investigate changes in the concentrations of glucagon in the plasma and glycogen and cyclic AMP in the liver of the female mouse over a 24 h period.
Female mice (C3HS strain), 19–21 weeks old, were kept at a constant temperature (25 ± 1·0 °C) under a schedule of 12 h light : 12 h darkness (lights on 06.00–18.00 h) and allowed free
Search for other papers by B Maiztegui in
Google Scholar
PubMed
Search for other papers by M I Borelli in
Google Scholar
PubMed
Search for other papers by M L Massa in
Google Scholar
PubMed
Search for other papers by H Del Zotto in
Google Scholar
PubMed
Search for other papers by J J Gagliardino in
Google Scholar
PubMed
Administration of a sucrose-rich diet (SRD) to normal hamsters induces an insulin-resistant state and a significant increase of insulin secretion and β-cell mass. Islets isolated from these animals had a marked increase in glucose metabolism and glucose-induced insulin secretion, at both low and high glucose concentrations. They also presented increased hexokinase (HK) activity, without measurable changes in glucokinase (GK) activity. In this study we measured HK and GK activity in homogenates of islets isolated from normal control and SRD-fed hamsters, as well as in their particulate and cytosolic fractions. We also measured transcription rate (mRNA by reverse transcriptase PCR) and expression levels (Western blotting) of both enzymes in these islets. We found an increase in HK activity and expression levels, without measurable changes in HK mRNA level in SRD-fed animals. Whereas a similar GK activity was measured in homogenates of islets isolated from both groups, such activity was significantly higher in the cytosolic fraction of SRD islets. On the other hand, GK transcription rate and expression level were similar in both experimental groups. Our results suggest that the increased β-cell secretory response to low glucose can be partly ascribed to an increased activity of islet HK consecutive to an enhanced expression of the enzyme, while the enhanced response to high glucose could be due to changes in GK compartmentalization.
Search for other papers by Helena C Barbosa in
Google Scholar
PubMed
Search for other papers by Silvana Bordin in
Google Scholar
PubMed
Search for other papers by Gabriel Anhê in
Google Scholar
PubMed
Search for other papers by Shanta J Persaud in
Google Scholar
PubMed
Search for other papers by James Bowe in
Google Scholar
PubMed
Search for other papers by Maria I Borelli in
Google Scholar
PubMed
Search for other papers by Juan J Gagliardino in
Google Scholar
PubMed
Search for other papers by Antonio C Boschero in
Google Scholar
PubMed
Islet neogenesis associated protein (INGAP) increases islet mass and insulin secretion in neonatal and adult rat islets. In the present study, we measured the short- and long-term effects of INGAP-PP (a pentadecapeptide having the 104–118 amino acid sequence of INGAP) upon islet protein expression and phosphorylation of components of the PI3K, MAPK and cholinergic pathways, and on insulin secretion. Short-term exposure of neonatal islets to INGAP-PP (90 s, 5, 15, and 30 min) significantly increased Akt1-Ser473 and MAPK3/1-Thr202/Tyr204 phosphorylation and INGAP-PP also acutely increased insulin secretion from islets perifused with 2 and 20 mM glucose. Islets cultured for 4 days in the presence of INGAP-PP showed an increased expression of Akt1, Frap1, and Mapk1 mRNAs as well as of the muscarinic M3 receptor subtype, and phospholipase C (PLC)-β2 proteins. These islets also showed increased Akt1 and MAPK3/1 protein phosphorylation. Brief exposure of INGAP-PP-treated islets to carbachol (Cch) significantly increased P70S6K-Thr389 and MAPK3/1 phosphorylation and these islets released more insulin when challenged with Cch that was prevented by the M3 receptor antagonist 4-DAMP, in a concentration-dependent manner. In conclusion, these data indicate that short- and long-term exposure to INGAP-PP significantly affects the expression and the phosphorylation of proteins involved in islet PI3K and MAPK signaling pathways. The observations of INGAPP-PP-stimulated up-regulation of cholinergic M3 receptors and PLC-β2 proteins, enhanced P70S6K and MAPK3/1 phosphorylation and Cch-induced insulin secretion suggest a participation of the cholinergic pathway in INGAP-PP-mediated effects.
Search for other papers by H Del Zotto in
Google Scholar
PubMed
Search for other papers by M I Borelli in
Google Scholar
PubMed
Search for other papers by L Flores in
Google Scholar
PubMed
Search for other papers by M E García in
Google Scholar
PubMed
Search for other papers by C L Gómez Dumm in
Google Scholar
PubMed
Search for other papers by A Chicco in
Google Scholar
PubMed
Search for other papers by Y B Lombardo in
Google Scholar
PubMed
Search for other papers by J J Gagliardino in
Google Scholar
PubMed
This study aimed to determine the relative importance of different functional and morphological pancreatic changes induced by the chronic administration of a sucrose-rich diet (SRD) to maintain normal glucose homeostasis. Male Wistar rats were fed either sucrose (SRD) or starch (CD) for 6 and 12 months. At both periods, serum glucose and triacylglycerol levels were significantly higher (P<0.05; paired and unpaired Student’s t-test) in SRD rats. Serum insulin levels were significantly lower in SRD only at 12 months. At 6 months, the insulin secretion dose–response curve in SRD rats showed a shift to the left that was no longer observed at 12 months, when SRD islets decreased their response to 16 mM glucose. At 6 months, SRD rats showed a significant increase in β-cell volume density (Vvi) and islet cell replication rate, together with a decrease in β-cell apoptotic rate. Changes were not detected in the percentage of PDX-1- and islet neogenesis associated protein (INGAP)-positive cells. Conversely, at 12 months, there was a significant decrease in β-cell Vvi and in the percentage of PDX-1-positive cells; the islet cell replication rate was not modified, and the number of apoptotic β-cells increased significantly. No signs of increased neogenesis or INGAP-positive cells were recorded at any period in SRD rats. Our results show that SRD rats are unable to develop functional and morphological pancreatic reactive changes sufficient to maintain normal glucose and triacylglycerol levels for a long period. Such failure could be ascribed to their inability to increase the rate of neogenesis and of INGAP production.
